FDA Gives A Nod To "Paradigm Shifting" Cancer Treatment

Newswise — A key committee for the U.S. Food and Drug Administration issued a first-of-its-kind recommendation this week, unanimously signing off on an experimental cancer treatment. Research for the treatment was funded, in part, by a Connecticut nonprofit.

The therapy is called “CAR-T.”

Read the full article from WNPR at http://wnpr.org/post/fda-gives-nod-paradigm-shifting-cancer-treatment